abstract |
Certain embodiments provide a pharmaceutical composition comprising: a protein molecule comprising an ERT enzyme-Fc fusion polypeptide and a modified Fc polypeptide; buffer; and isotonic agents (eg, salts); wherein the pH of the pharmaceutical composition is between about 5.5 and 7.0, also provided is a method of using the same. |